Matches in SemOpenAlex for { <https://semopenalex.org/work/W3034304818> ?p ?o ?g. }
- W3034304818 endingPage "104023" @default.
- W3034304818 startingPage "104023" @default.
- W3034304818 abstract "A series of novel coumarin-based N-hydroxycinnamamide derivatives were designed and synthesized as histone deacetylase (HDAC) inhibitors. Most of the synthesized compounds showed potent HDAC inhibitory activity and significant antiproliferative activity against human cancer cell lines MCF-7, HepG2, HeLa and HCT-116. Among them, compound 14f displayed the most potent HDAC inhibition, especially against HDAC1 with IC50 value of 0.19 μM, which was better than that of SAHA (IC50 = 0.23 μM). It also showed the strongest antiproliferative activity towards HeLa cells and more than 26-fold selectivity for HDAC1 compared with HDAC6. Molecular docking studies revealed the possible binding modes of compound 14f into the two isoforms and provided a reasonable explanation for the selectivity. In addition, compound 14f could inhibit colony formation, upregulate the acetylation level of histone H3, and induce apoptosis and cell cycle arrest at G2/M phase in HeLa cells. Taken together, these results highlighted that compound 14f might be a promising HDAC inhibitor for cancer therapy." @default.
- W3034304818 created "2020-06-19" @default.
- W3034304818 creator A5019174025 @default.
- W3034304818 creator A5035282947 @default.
- W3034304818 creator A5047535787 @default.
- W3034304818 creator A5053139417 @default.
- W3034304818 creator A5057233052 @default.
- W3034304818 creator A5065450491 @default.
- W3034304818 creator A5067029768 @default.
- W3034304818 creator A5068340353 @default.
- W3034304818 creator A5069583338 @default.
- W3034304818 creator A5077655388 @default.
- W3034304818 creator A5085341997 @default.
- W3034304818 date "2020-08-01" @default.
- W3034304818 modified "2023-10-14" @default.
- W3034304818 title "Design, synthesis and biological evaluation of coumarin-based N-hydroxycinnamamide derivatives as novel histone deacetylase inhibitors with anticancer activities" @default.
- W3034304818 cites W1161204293 @default.
- W3034304818 cites W1975692560 @default.
- W3034304818 cites W1980131884 @default.
- W3034304818 cites W1985970694 @default.
- W3034304818 cites W1997842655 @default.
- W3034304818 cites W2003394088 @default.
- W3034304818 cites W2021172314 @default.
- W3034304818 cites W2031110581 @default.
- W3034304818 cites W2059914085 @default.
- W3034304818 cites W2085769337 @default.
- W3034304818 cites W2112351720 @default.
- W3034304818 cites W2119870623 @default.
- W3034304818 cites W2153704476 @default.
- W3034304818 cites W2165638033 @default.
- W3034304818 cites W2167602894 @default.
- W3034304818 cites W2168457230 @default.
- W3034304818 cites W2345952503 @default.
- W3034304818 cites W2404368222 @default.
- W3034304818 cites W2408743616 @default.
- W3034304818 cites W2560511362 @default.
- W3034304818 cites W2595278577 @default.
- W3034304818 cites W2745508963 @default.
- W3034304818 cites W2762912207 @default.
- W3034304818 cites W2887410227 @default.
- W3034304818 cites W2889276436 @default.
- W3034304818 cites W2889646458 @default.
- W3034304818 cites W2891710083 @default.
- W3034304818 cites W2891764087 @default.
- W3034304818 cites W2900781628 @default.
- W3034304818 cites W2915619589 @default.
- W3034304818 cites W2920068846 @default.
- W3034304818 cites W2937001882 @default.
- W3034304818 cites W2939823621 @default.
- W3034304818 cites W2945783324 @default.
- W3034304818 cites W2948995783 @default.
- W3034304818 cites W2959493622 @default.
- W3034304818 cites W2966507386 @default.
- W3034304818 cites W2969925621 @default.
- W3034304818 cites W2986725005 @default.
- W3034304818 cites W2989630699 @default.
- W3034304818 cites W3016365688 @default.
- W3034304818 cites W4255691026 @default.
- W3034304818 doi "https://doi.org/10.1016/j.bioorg.2020.104023" @default.
- W3034304818 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32650178" @default.
- W3034304818 hasPublicationYear "2020" @default.
- W3034304818 type Work @default.
- W3034304818 sameAs 3034304818 @default.
- W3034304818 citedByCount "12" @default.
- W3034304818 countsByYear W30343048182020 @default.
- W3034304818 countsByYear W30343048182021 @default.
- W3034304818 countsByYear W30343048182022 @default.
- W3034304818 countsByYear W30343048182023 @default.
- W3034304818 crossrefType "journal-article" @default.
- W3034304818 hasAuthorship W3034304818A5019174025 @default.
- W3034304818 hasAuthorship W3034304818A5035282947 @default.
- W3034304818 hasAuthorship W3034304818A5047535787 @default.
- W3034304818 hasAuthorship W3034304818A5053139417 @default.
- W3034304818 hasAuthorship W3034304818A5057233052 @default.
- W3034304818 hasAuthorship W3034304818A5065450491 @default.
- W3034304818 hasAuthorship W3034304818A5067029768 @default.
- W3034304818 hasAuthorship W3034304818A5068340353 @default.
- W3034304818 hasAuthorship W3034304818A5069583338 @default.
- W3034304818 hasAuthorship W3034304818A5077655388 @default.
- W3034304818 hasAuthorship W3034304818A5085341997 @default.
- W3034304818 hasConcept C104317684 @default.
- W3034304818 hasConcept C105696609 @default.
- W3034304818 hasConcept C119157956 @default.
- W3034304818 hasConcept C121608353 @default.
- W3034304818 hasConcept C1491633281 @default.
- W3034304818 hasConcept C159110408 @default.
- W3034304818 hasConcept C178790620 @default.
- W3034304818 hasConcept C185592680 @default.
- W3034304818 hasConcept C190283241 @default.
- W3034304818 hasConcept C202751555 @default.
- W3034304818 hasConcept C23681527 @default.
- W3034304818 hasConcept C25737173 @default.
- W3034304818 hasConcept C2776202225 @default.
- W3034304818 hasConcept C2777366897 @default.
- W3034304818 hasConcept C2777752497 @default.
- W3034304818 hasConcept C2778305200 @default.
- W3034304818 hasConcept C2781338262 @default.
- W3034304818 hasConcept C29537977 @default.